Published in Br J Pharmacol on December 15, 2014
Tissue-specific up-regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus. Br J Pharmacol (2015) 0.81
Diastolic dysfunction in prediabetic male rats: Role of mitochondrial oxidative stress. Am J Physiol Heart Circ Physiol (2016) 0.78
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). Redox Biol (2017) 0.77
Pharmacology of the 'gasotransmitters' NO, CO and H2S: translational opportunities. Br J Pharmacol (2015) 0.77
Nitric oxide treatments as adjuncts to reperfusion in acute myocardial infarction: a systematic review of experimental and clinical studies. Basic Res Cardiol (2016) 0.75
Inorganic Nitrate in Angina Study: A Randomized Double-Blind Placebo-Controlled Trial. J Am Heart Assoc (2017) 0.75
Free radicals in the physiological control of cell function. Physiol Rev (2002) 19.62
Nitric oxide and peroxynitrite in health and disease. Physiol Rev (2007) 15.49
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucleic Acids Res (2013) 9.61
Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest (2003) 6.30
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol (2013) 5.74
Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A (2000) 5.65
Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med (2013) 5.60
The Concise Guide to PHARMACOLOGY 2013/14: enzymes. Br J Pharmacol (2013) 5.57
Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med (2013) 5.22
Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 5.09
Treatment of hypertension with ascorbic acid. Lancet (1999) 4.74
A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest (2001) 4.35
Molecular mechanisms of myocardial remodeling. Physiol Rev (1999) 4.27
Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci U S A (1996) 3.83
Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation (1998) 3.25
The Concise Guide to PHARMACOLOGY 2013/14: ion channels. Br J Pharmacol (2013) 3.03
Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest (1995) 2.94
Amino acids: metabolism, functions, and nutrition. Amino Acids (2009) 2.92
Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest (2002) 2.89
Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol (1999) 2.87
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov (2006) 2.84
Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ Res (2004) 2.50
Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease. Circulation (2011) 2.48
Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo. Circulation (2003) 2.35
Sympathetic neural activation in visceral obesity. Circulation (2002) 2.34
Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol (2003) 2.26
The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes (2002) 2.20
Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ Res (2008) 2.19
Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. Circulation (2012) 2.14
Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation (2002) 2.14
Arginine metabolism and nutrition in growth, health and disease. Amino Acids (2008) 2.13
The Concise Guide to PHARMACOLOGY 2013/14: transporters. Br J Pharmacol (2013) 2.07
eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol Metab (2009) 2.04
Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress. Hypertension (2007) 1.93
Dietary nitrite prevents hypercholesterolemic microvascular inflammation and reverses endothelial dysfunction. Am J Physiol Heart Circ Physiol (2009) 1.89
Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Diabetes (2002) 1.83
Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J (2002) 1.73
Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem (2005) 1.72
The Concise Guide to PHARMACOLOGY 2013/14: nuclear hormone receptors. Br J Pharmacol (2013) 1.70
Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res (2002) 1.69
Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol (2005) 1.68
Is oxidative stress a therapeutic target in cardiovascular disease? Eur Heart J (2010) 1.67
Effects of tempol and redox-cycling nitroxides in models of oxidative stress. Pharmacol Ther (2010) 1.66
Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart (2005) 1.65
Reversal of inducible nitric oxide synthase uncoupling unmasks tolerance to ischemia/reperfusion injury in the diabetic rat heart. J Mol Cell Cardiol (2010) 1.64
Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes (1999) 1.64
Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Circulation (2011) 1.62
Leptin and cardiovascular disease: response to therapeutic interventions. Circulation (2008) 1.58
Activation of peroxisome proliferator-activated receptor-alpha by fenofibrate prevents myocardial dysfunction during endotoxemia in rats. Crit Care Med (2007) 1.57
Paracrine and autocrine effects of nitric oxide on myocardial function. Pharmacol Ther (2000) 1.54
Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes (2000) 1.54
LA419, a novel nitric oxide donor, prevents pathological cardiac remodeling in pressure-overloaded rats via endothelial nitric oxide synthase pathway regulation. Hypertension (2007) 1.53
PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes. Am J Physiol Heart Circ Physiol (2003) 1.43
Caveolins and the regulation of endothelial nitric oxide synthase in the heart. Cardiovasc Res (2006) 1.43
Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO. Hypertension (2000) 1.42
Phosphodiesterase regulation of nitric oxide signaling. Cardiovasc Res (2007) 1.38
Endoplasmic reticulum stress is involved in cardiac damage and vascular endothelial dysfunction in hypertensive mice. Arterioscler Thromb Vasc Biol (2012) 1.37
Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium. J Cell Mol Med (2008) 1.36
Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme. Antioxid Redox Signal (2005) 1.28
Upregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen species. Am J Hypertens (2008) 1.25
Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats. J Nutr (2010) 1.23
Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of Thioredoxin 2. Hypertension (2009) 1.23
Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries. Am J Physiol Heart Circ Physiol (2002) 1.22
Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs. Nitric Oxide (2002) 1.20
Characteristics and function of cardiac mitochondrial nitric oxide synthase. J Physiol (2008) 1.20
Hyperlipidemia induced by a cholesterol-rich diet leads to enhanced peroxynitrite formation in rat hearts. Cardiovasc Res (2003) 1.19
PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway. Am J Physiol Heart Circ Physiol (2009) 1.19
ATP-sensitive K(+) channel activation by nitric oxide and protein kinase G in rabbit ventricular myocytes. Am J Physiol Heart Circ Physiol (2002) 1.18
Oxidative stress and myocardial injury in the diabetic heart. J Pathol (2013) 1.18
Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase. Am J Physiol Heart Circ Physiol (2001) 1.17
Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats. Endocrinology (2013) 1.15
'Pressure-flow'-triggered intracellular Ca2+ transients in rat cardiac myocytes: possible mechanisms and role of mitochondria. J Physiol (2008) 1.15
Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats. Endocrinology (2007) 1.11
Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol (2000) 1.10
Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension. Am Heart J (2004) 1.10
Positive effects of nitric oxide on left ventricular function in humans. Eur Heart J (2006) 1.10
Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy. Diabetes (2012) 1.10
Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging. Am J Physiol Heart Circ Physiol (2010) 1.09
MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart. J Mol Cell Cardiol (2013) 1.09
Insulin modulates leptin-induced STAT3 activation in rat hypothalamus. FEBS Lett (2001) 1.09
Reduced neuronal nitric oxide synthase expression contributes to cardiac oxidative stress and nitroso-redox imbalance in ob/ob mice. Nitric Oxide (2006) 1.08
Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide. Kidney Int (2002) 1.07
Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders. Free Radic Biol Med (2010) 1.06
Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy. J Cell Mol Med (2008) 1.05
Hypertension, nitric oxide, oxidants, and dietary plant polyphenols. Curr Pharm Biotechnol (2010) 1.05
Soluble guanylate cyclase stimulation prevents fibrotic tissue remodeling and improves survival in salt-sensitive Dahl rats. PLoS One (2011) 1.04
Role of mitochondrial oxidative stress in hypertension. Am J Physiol Heart Circ Physiol (2013) 1.04
Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite. Am J Physiol Heart Circ Physiol (2009) 1.04
The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin. Am J Physiol Heart Circ Physiol (2008) 1.03
Peroxynitrite: just an oxidative/nitrosative stressor or a physiological regulator as well? Br J Pharmacol (2006) 1.02
The neuroendocrine control of glucose allocation. Exp Clin Endocrinol Diabetes (2002) 1.02
Modulating endothelial nitric oxide synthase: a new cardiovascular therapeutic strategy. Am J Physiol Heart Circ Physiol (2011) 1.02
Flow-induced remodeling in resistance arteries from obese Zucker rats is associated with endothelial dysfunction. Hypertension (2007) 1.02
Hypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic mice. Cardiovasc Res (2007) 1.01
Heme oxygenase in diabetes-induced oxidative stress in the heart. J Mol Cell Cardiol (2003) 1.01
The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning. Br J Pharmacol (2014) 1.01
The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation. Am J Physiol Heart Circ Physiol (2007) 1.00
Hypertensive myocardial fibrosis. Nephrol Dial Transplant (2005) 1.00
Diet-induced renal changes in Zucker rats are ameliorated by the superoxide dismutase mimetic TEMPOL. Obesity (Silver Spring) (2009) 1.00
Effects of NO on mitochondrial function in cardiomyocytes: Pathophysiological relevance. Cardiovasc Res (2006) 1.00
Control of apoptosis by IP(3) and ryanodine receptor driven calcium signals. Cell Calcium (2001) 1.55
Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling. Br J Pharmacol (2007) 1.52
The machinery of local Ca2+ signalling between sarco-endoplasmic reticulum and mitochondria. J Physiol (2000) 1.46
Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase. Circ Res (2001) 1.39
CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration. Br J Pharmacol (2007) 1.32
Early diabetes-induced biochemical changes in the retina: comparison of rat and mouse models. Diabetologia (2006) 1.11
Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy. Diabetologia (2004) 1.08
Increased myogenic tone in skeletal muscle arterioles of diabetic rats. Possible role of increased activity of smooth muscle Ca2+ channels and protein kinase C. Cardiovasc Res (1999) 1.07
Peroxynitrite activates ERK via Raf-1 and MEK, independently from EGF receptor and p21Ras in H9C2 cardiomyocytes. J Mol Cell Cardiol (2005) 1.05
Inosine reduces systemic inflammation and improves survival in septic shock induced by cecal ligation and puncture. Am J Respir Crit Care Med (2001) 1.05
Inosine reduces inflammation and improves survival in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol (2002) 1.02
Matrix metalloproteinase activity assays: Importance of zymography. J Pharmacol Toxicol Methods (2010) 1.00
Increased fear- and stress-related anxiety-like behavior in mice lacking tuberoinfundibular peptide of 39 residues. Genes Brain Behav (2008) 1.00
Classic preconditioning decreases the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts. Circulation (1999) 0.99
Nicotine reduces the incidence of type I diabetes in mice. J Pharmacol Exp Ther (2002) 0.97
Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia. Arterioscler Thromb Vasc Biol (1999) 0.96
Delayed preconditioning of myocardium: current perspectives. Basic Res Cardiol (2001) 0.96
Peroxynitrite: toxic or protective in the heart? Circ Res (2001) 0.96
Mechanism of vasodilation by cochlear nerve stimulation. Role of calcitonin gene-related peptide. Pharmacol Res (1999) 0.95
Fluoxetine dilates isolated small cerebral arteries of rats and attenuates constrictions to serotonin, norepinephrine, and a voltage-dependent Ca(2+) channel opener. Stroke (1999) 0.94
Muscle soreness-induced reduction in force generation is accompanied by increased nitric oxide content and DNA damage in human skeletal muscle. Free Radic Biol Med (1999) 0.94
Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells. Neuropharmacology (2000) 0.93
Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line. Diabetologia (2011) 0.92
Anti-inflammatory effects of inosine in human monocytes, neutrophils and epithelial cells in vitro. Int J Mol Med (2001) 0.90
Resonant enhancement of two-photon absorption in substituted fluorene molecules. J Chem Phys (2004) 0.90
The loss of pacing-induced preconditioning in atherosclerotic rabbits: role of hypercholesterolaemia. J Mol Cell Cardiol (1995) 0.88
Heme oxygenase and cardiac function in ischemic/reperfused rat hearts. Free Radic Biol Med (1999) 0.87
Ventricular overdrive pacing-induced anti-ischemic effect: a conscious rabbit model of preconditioning. Am J Physiol (1994) 0.87
Delayed cardiac protection against harmful consequences of stress can be induced in experimental atherosclerosis in rabbits. J Mol Cell Cardiol (1997) 0.87
The protective effect of EGb 761 in isolated ischemic/reperfused rat hearts: a link between cardiac function and nitric oxide production. J Cardiovasc Pharmacol (1999) 0.87
Preconditioning decreases ischemia/reperfusion-induced peroxynitrite formation. Biochem Biophys Res Commun (2001) 0.87
Serotonin reuptake inhibitor fluoxetine decreases arteriolar myogenic tone by reducing smooth muscle [Ca2+]i. J Cardiovasc Pharmacol (2000) 0.86
Hyperlipidaemia induced by a high-cholesterol diet leads to the deterioration of guanosine-3',5'-cyclic monophosphate/protein kinase G-dependent cardioprotection in rats. Br J Pharmacol (2009) 0.85
Lack of correlation between myocardial nitric oxide and cyclic guanosine monophosphate content in both nitrate-tolerant and -nontolerant rats. Biochem Pharmacol (1998) 0.85
Impairment by lovastatin of neural relaxation of the rabbit sphincter of Oddi. Eur J Pharmacol (2001) 0.85
Zaprinast, cicletanine, and verapamil attenuate overdrive pacing-induced myocardial ischemia in conscious rabbits. Life Sci (1993) 0.84
Cardiac capsaicin-sensitive sensory nerves regulate myocardial relaxation via S-nitrosylation of SERCA: role of peroxynitrite. Br J Pharmacol (2007) 0.84
Loss of preconditioning in rabbits with vascular tolerance to nitroglycerin. Br J Pharmacol (1994) 0.83
Glucocorticoid receptor dimerization is required for proper recovery of LPS-induced inflammation, sickness behavior and metabolism in mice. Mol Psychiatry (2012) 0.83
Spatio-temporal organization of the mitochondrial phase of apoptosis. IUBMB Life (2002) 0.82
The adenosine A2A receptor agonist CGS 21680 fails to ameliorate the course of dextran sulphate-induced colitis in mice. Inflamm Res (2007) 0.82
Purification of high-quality micro RNA from the heart tissue. Acta Biol Hung (2011) 0.81
Direct myocardial anti-ischaemic effect of GTN in both nitrate-tolerant and nontolerant rats: a cyclic GMP-independent activation of KATP. Br J Pharmacol (1999) 0.81
Oxidative stress-induced isoprostane formation may contribute to aspirin resistance in platelets. Prostaglandins Leukot Essent Fatty Acids (2002) 0.81
Antiischemic effect of monophosphoryl lipid A in conscious rabbits with hypercholesterolemia and atherosclerosis. J Cardiovasc Pharmacol (1998) 0.81
Hyperglycaemia alters the endothelium-dependent relaxation of canine coronary arteries. Acta Physiol Scand (2000) 0.80
Comparative study of cardiac electrophysiological effects of atrial natriuretic peptide. Mol Cell Biochem (1997) 0.80
Super-marathon race increases serum and urinary nitrotyrosine and carbonyl levels. Eur J Clin Invest (2003) 0.80
Nitric oxide is an important determinant of coronary flow in the isolated blood perfused rat heart. Basic Res Cardiol (1993) 0.80
Cardioprotective effects of the calcineurin inhibitor FK506 and the PAF receptor antagonist and free radical scavenger, EGb 761, in isolated ischemic/reperfused rat hearts. J Cardiovasc Pharmacol (2000) 0.80
Role of slow delayed rectifier K+-current in QT prolongation in the alloxan-induced diabetic rabbit heart. Acta Physiol (Oxf) (2007) 0.79
Interaction between capsaicin and nitrate tolerance in isolated guinea-pig heart. Eur J Pharmacol (1999) 0.79
Cytoprotection by the NO-donor SNAP against ischemia/reoxygenation injury in mouse embryonic stem cell-derived cardiomyocytes. Mol Biotechnol (2014) 0.79
Nitric oxide, peroxynitrite and cGMP in atherosclerosis-induced hypertension in rabbits: beneficial effects of cicletanine. J Vasc Res (2001) 0.79
Functional and structural pattern of arterial responses in hereditary hypertriglyceridemic and spontaneously hypertensive rats in early stage of experimental hypertension. Physiol Res (2006) 0.79
The effect of continuous versus intermittent treatment with transdermal nitroglycerin on pacing-induced preconditioning in conscious rabbits. Br J Pharmacol (1997) 0.79
Hereditary hypertriglyceridemic rat: a suitable model of cardiovascular disease and metabolic syndrome? Physiol Res (2006) 0.78
Effect of transdermal nitroglycerin on glucose-stimulated insulin release in healthy male volunteers. Eur J Clin Invest (2000) 0.78
Measurement of NO in biological samples. Br J Pharmacol (2014) 0.78
Deterioration of the protein kinase C-K(ATP) channel pathway in regulation of coronary flow in hypercholesterolaemic rabbits. Eur J Pharmacol (2001) 0.78
Cromakalim and cicletanine against pacing-induced myocardial ischemia in conscious rabbits. Life Sci (1994) 0.78
Protective effect of ischaemic preconditioning on ischaemia/reperfusion-induced microvascular obstruction determined by on-line measurements of coronary pressure and blood flow in pigs. Thromb Haemost (2009) 0.77
Long-term effects of early administered sildenafil and NO donor on the cardiovascular system of SHR. J Physiol Pharmacol (2007) 0.77
Improvement of cardiac allograft function by 1400W, a highly selective inducible nitric oxide synthase inhibitor and superoxide dismutase - role of peroxynitrite. J Heart Lung Transplant (2001) 0.76
Acetylcholine and bradykinin enhance hypotension and affect the function of remodeled conduit arteries in SHR and SHR treated with nitric oxide donors. Braz J Med Biol Res (2005) 0.75
Can the electrophysiological action of rosiglitazone explain its cardiac side effects? Curr Med Chem (2011) 0.75
Comparison of vascular function and structure of iliac artery in spontaneously hypertensive and hereditary hypertriglyceridemic rats. Physiol Res (2006) 0.75
Involvement of glibenclamide-sensitive potassium channels in vasorelaxation by cochlear nerve stimulation. Eur Arch Otorhinolaryngol (1997) 0.75
Can simvastatin promote tumor growth by inducing angiogenesis similar to VEGF? Med Hypotheses (2002) 0.75
Electrophysiological characteristics of ventricular muscles from diabetic hearts. Acta Physiol Hung (1996) 0.75